uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this registry is to evaluate real world experience and outcomes of patients with Upper Tract Urothelial Cancer (UTUC) treated with Jelmyto in the United States.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Dorośli powyżej 18 lat, którzy mogą świadomie wyrazić zgodę.
- •Diagnoza raka górnych dróg moczowych (UTUC).
- •Otrzymanie co najmniej jednej dawki leku JELMYTO po jego zatwierdzeniu przez FDA (15 kwietnia 2020 r.).
✗ Disqualifies
- •Osoby niezdolne do świadomego wyrażenia zgody (np. osoby osadzone, osoby z demencją).
- •Otrzymanie leku JELMYTO (znanego również jako UGN-101 lub Mitogel) przed zatwierdzeniem przez FDA (15 kwietnia 2020 r. lub wcześniej).
- •Ciąża lub karmienie piersią.
- •Niezdolność do przestrzegania wymogów badania (w przypadku zbierania danych na bieżąco).
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 29, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (22)
Providence St. Johns Health Center
Santa Monica, United States
University of Florida
Gainesville, United States
Mount Sinai Medical Center of Florida, Inc.
Miami, United States
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
Tampa, United States
Northwestern University
Chicago, United States
Indiana University
Indianapolis, United States
The State University of Iowa
Iowa City, United States
Chesapeake Urology
Baltimore, United States
Johns Hopkins Medical Center
Baltimore, United States
Mass General Brigham
Boston, United States
Brigham and Women's Hospital
Boston, United States
University of Michigan
Ann Arbor, United States
University of Missouri
Columbia, United States
Rutgers
New Brunswick, United States
The Feinstein Institutes for Medical Research
Lake Success, United States
NYU Grossman School of Medicine
New York, United States
SUNY Upstate
Syracuse, United States
The University of North Carolina Chapel Hill
Chapel Hill, United States
Ohio State University
Columbus, United States
Vanderbilt University Medical Center
Nashville, United States
UT Southwestern Medical Center
Dallas, United States
The University of Texas M.D. Anderson Cancer Center
Houston, United States
Trial contact
Michael Louie, MD, MPH, MSc
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/30/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.